BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

359 related articles for article (PubMed ID: 34624198)

  • 1. Current epidemiology in hepatocellular carcinoma.
    Konyn P; Ahmed A; Kim D
    Expert Rev Gastroenterol Hepatol; 2021 Nov; 15(11):1295-1307. PubMed ID: 34624198
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disease Burden of Hepatocellular Carcinoma: A Global Perspective.
    Sayiner M; Golabi P; Younossi ZM
    Dig Dis Sci; 2019 Apr; 64(4):910-917. PubMed ID: 30835028
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Trends in hepatocellular carcinoma due to non-alcoholic fatty liver disease.
    Bertot LC; Adams LA
    Expert Rev Gastroenterol Hepatol; 2019 Feb; 13(2):179-187. PubMed ID: 30791782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis.
    Tang A; Hallouch O; Chernyak V; Kamaya A; Sirlin CB
    Abdom Radiol (NY); 2018 Jan; 43(1):13-25. PubMed ID: 28647765
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatocellular carcinoma prevention: a worldwide emergence between the opulence of developed countries and the economic constraints of developing nations.
    Lodato F; Mazzella G; Festi D; Azzaroli F; Colecchia A; Roda E
    World J Gastroenterol; 2006 Dec; 12(45):7239-49. PubMed ID: 17143937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Global Epidemiology, Prevention, and Management of Hepatocellular Carcinoma.
    Mak LY; Cruz-Ramón V; Chinchilla-López P; Torres HA; LoConte NK; Rice JP; Foxhall LE; Sturgis EM; Merrill JK; Bailey HH; Méndez-Sánchez N; Yuen MF; Hwang JP
    Am Soc Clin Oncol Educ Book; 2018 May; 38():262-279. PubMed ID: 30231359
    [TBL] [Abstract][Full Text] [Related]  

  • 7.  Economic growth leads to increase of obesity and associated hepatocellular carcinoma in developing countries.
    Seyda Seydel G; Kucukoglu O; Altinbasv A; Demir OO; Yilmaz S; Akkiz H; Otan E; Sowa JP; Canbay A
    Ann Hepatol; 2016; 15(5):662-72. PubMed ID: 27493104
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology of Liver Cancer in Africa: Current and Future Trends.
    Okeke E; Davwar PM; Roberts L; Sartorius K; Spearman W; Malu A; Duguru M
    Semin Liver Dis; 2020 May; 40(2):111-123. PubMed ID: 31726474
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological and etiological variations in hepatocellular carcinoma.
    Sagnelli E; Macera M; Russo A; Coppola N; Sagnelli C
    Infection; 2020 Feb; 48(1):7-17. PubMed ID: 31347138
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Influence of Metabolic Risk Factors on Risk of Hepatocellular Carcinoma and Liver-Related Death in Men With Chronic Hepatitis B: A Large Cohort Study.
    Yu MW; Lin CL; Liu CJ; Yang SH; Tseng YL; Wu CF
    Gastroenterology; 2017 Oct; 153(4):1006-1017.e5. PubMed ID: 28711626
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hepatocellular carcinoma: an epidemiologic view.
    El-Serag HB
    J Clin Gastroenterol; 2002; 35(5 Suppl 2):S72-8. PubMed ID: 12394209
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Declining hepatitis C virus-related liver disease burden in the direct-acting antiviral therapy era in New South Wales, Australia.
    Alavi M; Law MG; Valerio H; Grebely J; Amin J; Hajarizadeh B; Selvey C; George J; Dore GJ
    J Hepatol; 2019 Aug; 71(2):281-288. PubMed ID: 31078544
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidemiology of chronic hepatitis B virus infection, hepatocellular carcinoma, and hepatitis B virus-induced hepatocellular carcinoma.
    Kew MC
    Pathol Biol (Paris); 2010 Aug; 58(4):273-7. PubMed ID: 20378277
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hepatocellular carcinoma and non-alcoholic fatty liver disease.
    Golabi P; Rhea L; Henry L; Younossi ZM
    Hepatol Int; 2019 Nov; 13(6):688-694. PubMed ID: 31701393
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epidemiology of hepatocellular carcinoma: consider the population.
    Mittal S; El-Serag HB
    J Clin Gastroenterol; 2013 Jul; 47 Suppl(0):S2-6. PubMed ID: 23632345
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hepatocellular carcinoma. A worldwide problem and the major risk factors.
    Simonetti RG; Cammà C; Fiorello F; Politi F; D'Amico G; Pagliaro L
    Dig Dis Sci; 1991 Jul; 36(7):962-72. PubMed ID: 1649041
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nonalcoholic fatty liver disease, metabolic risk factors, and hepatocellular carcinoma: an open question.
    Streba LA; Vere CC; Rogoveanu I; Streba CT
    World J Gastroenterol; 2015 Apr; 21(14):4103-10. PubMed ID: 25892859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epidemiology of hepatocellular carcinoma in areas of low hepatitis B and hepatitis C endemicity.
    Seeff LB; Hoofnagle JH
    Oncogene; 2006 Jun; 25(27):3771-7. PubMed ID: 16799618
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epidemiology and natural history of hepatocellular carcinoma.
    McGlynn KA; London WT
    Best Pract Res Clin Gastroenterol; 2005 Feb; 19(1):3-23. PubMed ID: 15757802
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Epidemiology of Hepatocellular Carcinoma in the USA.
    Kim HS; El-Serag HB
    Curr Gastroenterol Rep; 2019 Apr; 21(4):17. PubMed ID: 30976932
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.